FCRN Clinical Trial Centre

Vereeniging, Gauteng 1935

0 studies enrolling now · 7 studies all time

What they study most

COVID-19, Chronic Spontaneous Urticaria, Covid19, Influenza, Human, Lower Respiratory Tract Illness, Pneumonia, Bacterial, Severe Asthma

Studies at this site

• A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) — Completed
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia — Running, not enrolling
• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
• Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease — Stopped early
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early